Tags

Type your tag names separated by a space and hit enter

Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children.
Clin Infect Dis 2015; 61 Suppl 8:S856-64CI

Abstract

Survivors of sexual assault are at risk for acquiring sexually transmitted infections (STIs). We conducted literature reviews and invited experts to assist in updating the sexual assault section for the 2015 Centers for Disease Control and Prevention sexually transmitted diseases (STD) treatment guidelines. New recommendations for STI management among adult and adolescent sexual assault survivors include use of nucleic acid amplification tests (NAATs) for detection of Trichomonas vaginalis by vaginal swabs; NAATs for detection of Neisseria gonorrhoeae and Chlamydia trachomatis from pharyngeal and rectal specimens among patients with a history of exposure or suspected extragenital contact after sexual assault; empiric therapy for gonorrhea, chlamydia, and trichomoniasis based on updated treatment regimens; vaccinations for human papillomavirus (HPV) among previously unvaccinated patients aged 9-26 years; and consideration for human immunodeficiency virus (HIV) nonoccupational postexposure prophylaxis using an algorithm to assess the timing and characteristics of the exposure. For child sexual assault (CSA) survivors, recommendations include targeted diagnostic testing with increased use of NAATs when appropriate; routine follow-up visits within 6 months after the last known sexual abuse; and use of HPV vaccination in accordance with national immunization guidelines as a preventive measure in the post-sexual assault care setting. For CSA patients, NAATs are considered to be acceptable for identification of gonococcal and chlamydial infections from urine samples, but are not recommended for extragenital testing due to the potential detection of nongonococcal Neisseria species. Several research questions were identified regarding the prevalence, detection, and management of STI/HIV infections among adult, adolescent, and pediatric sexual assault survivors.

Authors+Show Affiliations

Institute for Global Health and Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill.Division of STD Prevention, Bureau of Infectious Diseases, Massachusetts Department of Public Health, Jamaica Plain.Division of Child Abuse Pediatrics, Department of Pediatrics, University of Texas Health Science Center at San Antonio.Division of Child Protection Pediatrics, Department of Pediatrics, University of Texas Health Science Center at Houston.Child Abuse and Neglect Prevention, Children's Hospital of Philadelphia, Pennsylvania.Department of Emergency Medicine, Boston Medical Center and Boston University School of Medicine, Massachusetts Massachusetts Sexual Assault Nurse Examiner Program, Massachusetts Department of Public Health, Boston.Women's Emergency Services, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas.Massachusetts Sexual Assault Nurse Examiner Program, Massachusetts Department of Public Health, Boston.Division of General Pediatrics, Department of Pediatrics, University of Washington, Seattle.Division of Pediatric Infectious Diseases, Department of Pediatrics, State University of New York Downstate Medical Center, Brooklyn.

Pub Type(s)

Journal Article
Research Support, U.S. Gov't, P.H.S.
Review

Language

eng

PubMed ID

26602623

Citation

Seña, Arlene C., et al. "Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 61 Suppl 8, 2015, pp. S856-64.
Seña AC, Hsu KK, Kellogg N, et al. Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children. Clin Infect Dis. 2015;61 Suppl 8:S856-64.
Seña, A. C., Hsu, K. K., Kellogg, N., Girardet, R., Christian, C. W., Linden, J., ... Hammerschlag, M. R. (2015). Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 61 Suppl 8, pp. S856-64. doi:10.1093/cid/civ786.
Seña AC, et al. Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children. Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S856-64. PubMed PMID: 26602623.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children. AU - Seña,Arlene C, AU - Hsu,Katherine K, AU - Kellogg,Nancy, AU - Girardet,Rebecca, AU - Christian,Cindy W, AU - Linden,Judith, AU - Griffith,William, AU - Marchant,Anne, AU - Jenny,Carole, AU - Hammerschlag,Margaret R, PY - 2015/11/26/entrez PY - 2015/11/26/pubmed PY - 2016/8/31/medline KW - child sexual abuse KW - sexual assault KW - sexually transmitted infections SP - S856 EP - 64 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin. Infect. Dis. VL - 61 Suppl 8 N2 - Survivors of sexual assault are at risk for acquiring sexually transmitted infections (STIs). We conducted literature reviews and invited experts to assist in updating the sexual assault section for the 2015 Centers for Disease Control and Prevention sexually transmitted diseases (STD) treatment guidelines. New recommendations for STI management among adult and adolescent sexual assault survivors include use of nucleic acid amplification tests (NAATs) for detection of Trichomonas vaginalis by vaginal swabs; NAATs for detection of Neisseria gonorrhoeae and Chlamydia trachomatis from pharyngeal and rectal specimens among patients with a history of exposure or suspected extragenital contact after sexual assault; empiric therapy for gonorrhea, chlamydia, and trichomoniasis based on updated treatment regimens; vaccinations for human papillomavirus (HPV) among previously unvaccinated patients aged 9-26 years; and consideration for human immunodeficiency virus (HIV) nonoccupational postexposure prophylaxis using an algorithm to assess the timing and characteristics of the exposure. For child sexual assault (CSA) survivors, recommendations include targeted diagnostic testing with increased use of NAATs when appropriate; routine follow-up visits within 6 months after the last known sexual abuse; and use of HPV vaccination in accordance with national immunization guidelines as a preventive measure in the post-sexual assault care setting. For CSA patients, NAATs are considered to be acceptable for identification of gonococcal and chlamydial infections from urine samples, but are not recommended for extragenital testing due to the potential detection of nongonococcal Neisseria species. Several research questions were identified regarding the prevalence, detection, and management of STI/HIV infections among adult, adolescent, and pediatric sexual assault survivors. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/26602623/Sexual_Assault_and_Sexually_Transmitted_Infections_in_Adults,_Adolescents,_and_Children L2 - https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/civ786 DB - PRIME DP - Unbound Medicine ER -